In my analysis, attention to mistakenly followed presumed processes, which ignore inadequate requirements and resulting insufficient budgets/schedules, causes typical risk analyses to miss almost certain repeated budget and schedule overruns. Once you become conscious that the real processes producing your results can differ from what you have been accustomed to presuming, your mind opens to allow awareness of all sorts of previously overlooked risks.

In this Advisor, we look at some of the concerns that organizations believe are hindering their customer experience adoption and implementation plans.

How can mHealth support the new challenges and opportunities of telehealth? In this issue of Cutter Business Technology Journal (CBTJ), we present some stimulating articles that illustrate the impact now, and the future direction, of mHealth.

How can mHealth support the new challenges and opportunities of telehealth? In this issue of Cutter Business Technology Journal (CBTJ), we present some stimulating articles that illustrate the impact now, and the future direction, of mHealth.

An organization’s business architecture represents the entire scope of what the organization does and the ecosystem in which it operates — at a high level of detail. This makes business architecture uniquely qualified to facilitate collaboration across silos and break them down when appropriate — something that almost no other disciplines or techniques can do. This Advisor shares some examples of why business architecture is so valuable for working across silos.

If the familiar VPNs are not up to the task of supporting the sudden new generation of WFH users, what’s the alternative? Fortunately, there’s a class of products designed specifically for today’s needs: cloud-based remote access software.

If the familiar VPNs are not up to the task of supporting the sudden new generation of WFH users, what’s the alternative? Fortunately, there’s a class of products designed specifically for today’s needs: cloud-based remote access software.

With a focus on brain health and neuroscience, Sean Lorenz describes how technology is helping us better assess our brain health journeys with remote detection, diagnosis, and treatment tools. Given the issues surrounding the COVID-19 pandemic, he explores the urgent need that requires the healthcare system to actively look toward telehealth and RPM.

With a focus on brain health and neuroscience, Sean Lorenz describes how technology is helping us better assess our brain health journeys with remote detection, diagnosis, and treatment tools. Given the issues surrounding the COVID-19 pandemic, he explores the urgent need that requires the healthcare system to actively look toward telehealth and RPM.

What’s happening when we’re reaching the right customers and meeting their strategic needs? That question is the opening gambit in an interesting kind of strategy review. In this Executive Update, we offer the design of two types of reviews — the OI-SR and OI-SDR — which together bring alignment and experiment­ation into prominence.

This article moves us up the healthcare value chain by highlighting the impact that COVID-19 has had on clinical trials. Cutter Consortium Senior Consultant Ben van der Schaaf and Pan Xi describe the current state of mHealth along with technology innovations that forward-looking R&D leaders in pharmaceuticals are deploying. Knowing that the current shift will not be temporary, the authors urge healthcare organizations “to adapt and be in the right place at the right time … to prepare for this imminent change.”

This article moves us up the healthcare value chain by highlighting the impact that COVID-19 has had on clinical trials. Cutter Consortium Senior Consultant Ben van der Schaaf and Pan Xi describe the current state of mHealth along with technology innovations that forward-looking R&D leaders in pharmaceuticals are deploying. Knowing that the current shift will not be temporary, the authors urge healthcare organizations “to adapt and be in the right place at the right time … to prepare for this imminent change.”

Heléne Spjuth examines the economics of mHealth and the resulting challenges and opportunities for all stakeholders in the healthcare ecosystem. In defining the healthcare ecosystem and its various reimbursement models, she shows the “unique circumstances that will serve either as barriers to, or enablers of, mHealth’s efficient implementation.”

Heléne Spjuth examines the economics of mHealth and the resulting challenges and opportunities for all stakeholders in the healthcare ecosystem. In defining the healthcare ecosystem and its various reimbursement models, she shows the “unique circumstances that will serve either as barriers to, or enablers of, mHealth’s efficient implementation.”

The process of residual analysis tests and proves (or disproves) the ability of the system to meet stressors for which it has not been designed. For those obvious stressors normally not included in a risk assessment, the process provides a method for analyzing how these stressors react when they occur in chains and eventually gives a sense of how the system behaves when exposed to stress in general.

The process of residual analysis tests and proves (or disproves) the ability of the system to meet stressors for which it has not been designed. For those obvious stressors normally not included in a risk assessment, the process provides a method for analyzing how these stressors react when they occur in chains and eventually gives a sense of how the system behaves when exposed to stress in general.

Unfortunately, for many decision makers in gov­ernment and industry today, practicing robust risk management is still seen within their organizations’ social context as providing little if any positive upside, but instead possessing potentially large downside conse­quences for them personally and professionally. Many decision makers skeptically view rigorous risk analysis as akin to future blame analysis for something that might go wrong rather than a way to increase career or organization success. Changing this perception is difficult but not impossible.

Levie Hofstee, cofounder of Neurocast, describes advancements made by his company. Neurocast is a later-stage startup gaining traction in using mHealth to provide real-world data on patients suffering from chronic disease, such as multiple sclerosis, both to aid new discoveries and to support 24/7 data collection during clinical trials.

Levie Hofstee, cofounder of Neurocast, describes advancements made by his company. Neurocast is a later-stage startup gaining traction in using mHealth to provide real-world data on patients suffering from chronic disease, such as multiple sclerosis, both to aid new discoveries and to support 24/7 data collection during clinical trials.

Customer journey insight allows businesses to increase customer satisfaction and loyalty, retain customers, and increase sales. In this Advisor, we make the case for stronger customer involvement, clearer governance, quantification of value, and a sharper focus, as we find these elements are the four main reasons implemen­tations of customer journeys fail.

In the drive to digitize more business processes, the intricacies of how all stakeholders inter­act with data have been underexposed. Though it is understandable that getting a grip on technology and reorganizing your business is hard enough, it is precisely this interaction that will determine your success. If you turn your perspective around, your data architecture will be of more value.

In this edition of the Cutter Edge, you'll explore a five-stage strategy execution scenario and the role of business architecture within each stage; how fast feedback processes, measurable outcomes, and empowerment can help businesses improve the quality and efficiency of their work; how shifting to IT development production lines can enhance software delivery, and more.

In this edition of the Cutter Edge, you'll explore a five-stage strategy execution scenario and the role of business architecture within each stage; how fast feedback processes, measurable outcomes, and empowerment can help businesses improve the quality and efficiency of their work; how shifting to IT development production lines can enhance software delivery, and more.

How interested are organizations in extending the capabilities of their RPA platforms and tools with more advanced, AI-based technologies? Fortunately, some initial findings from our ongoing survey on intelligent process automation (IPA) adoption in the enterprise helps shed some light on this question.

The COVID-19 pandemic has led to sizable disruptions in international economic activity, impacting all industries, although at different magnitudes. It is now time for decision makers to expand their focus beyond immediate crisis management to actions that will strengthen their competitive play in the medium and long term. Here in Part II of this Advisor series, we take a look at telecom, equipment vendors, and Internet services, in particular.